These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

417 related items for PubMed ID: 18076314

  • 1. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK.
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [Abstract] [Full Text] [Related]

  • 2. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D, Ruprecht K, Rieckmann P, Roggendorf W, Vince GH, Warmuth-Metz M, Kölbl O, Flentje M.
    BMC Cancer; 2006 Oct 18; 6():247. PubMed ID: 17049083
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spectrum of pediatric gliomas: implications for the development of future therapies.
    Pytel P.
    Expert Rev Anticancer Ther; 2007 Dec 18; 7(12 Suppl):S51-60. PubMed ID: 18076319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of PARP-1 and DNA-PK expression on survival in patients with glioblastoma multiforme.
    Kase M, Vardja M, Lipping A, Asser T, Jaal J.
    Radiother Oncol; 2011 Oct 18; 101(1):127-31. PubMed ID: 21775006
    [Abstract] [Full Text] [Related]

  • 8. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.
    Lutterbach J, Bartelt S, Momm F, Becker G, Frommhold H, Ostertag C.
    Cancer; 2005 Mar 15; 103(6):1234-44. PubMed ID: 15666327
    [Abstract] [Full Text] [Related]

  • 9. Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme.
    Briceño E, Calderon A, Sotelo J.
    Surg Neurol; 2007 Apr 15; 67(4):388-91. PubMed ID: 17350410
    [Abstract] [Full Text] [Related]

  • 10. Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
    Vordermark D, Kölbl O.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):296-7; author reply 297. PubMed ID: 15850943
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?
    Reznik E, Smith AW, Taube S, Mann J, Yondorf MZ, Parashar B, Wernicke AG.
    Am J Clin Oncol; 2018 Feb 01; 41(2):197-212. PubMed ID: 28906259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of glioblastoma multiforme: a new standard.
    Henson JW.
    Arch Neurol; 2006 Mar 01; 63(3):337-41. PubMed ID: 16533960
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
    Vymazal J, Wong ET.
    Semin Oncol; 2014 Oct 01; 41 Suppl 6():S14-24. PubMed ID: 25213870
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.